Willingness To Pay To Eliminate the Risk of Restenosis Following Percutaneous Coronary Intervention A Contingent Valuation

被引:2
|
作者
Guertin, Jason R. [1 ,2 ]
Liu, Aihua [3 ,4 ]
Abrahamowicz, Michal [3 ,4 ]
Cohen, David J. [6 ]
Ismail, Salma [2 ]
LeLorier, Jacques [1 ,2 ]
Brophy, James M. [3 ,4 ,5 ]
Rinfret, Stephane [2 ,7 ]
机构
[1] Univ Montreal, Montreal, PQ H3C 3J7, Canada
[2] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada
[3] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada
[5] McGill Univ, Ctr Hlth, Div Cardiol, Montreal, PQ, Canada
[6] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[7] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2011年 / 4卷 / 01期
关键词
restenosis; stents; cost-benefit analysis; SIROLIMUS-ELUTING STENTS; HIERARCHICAL BAYESIAN METAANALYSIS; HEALTH-CARE; COST-EFFECTIVENESS; ECONOMIC-EVALUATION; ANGIOPLASTY; TRIALS;
D O I
10.1161/CIRCOUTCOMES.109.915421
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Percutaneous coronary intervention (PCI) remains limited by the risk of restenosis. Patients' perceptions of the health benefits and value of avoiding restenosis are incompletely known. Methods and Results-We used a contingent valuation approach to assess the willingness to pay (WTP) for a hypothetical treatment that eliminates the risk of restenosis among 270 PCI patients. Patients were provided with a scenario describing a baseline 10% or 20% probability of restenosis in the year following the procedure, which could lead to repeat PCI or, more rarely, bypass surgery, without any increase in mortality. Six different "take it or leave it" bids ($500, $1000, $1500, $2000, $2500, and $3000) and both risk levels were randomly assigned. Multiple logistic regression was used to identify independent predictors of a positive response to the WTP question. Using nonparametric methods, the median WTP to eliminate the risk of restenosis was estimated at $2802. As expected, higher income was independently associated with a higher probability of a positive response to the WTP question (odds ratio, 2.81; 95% CI, 1.32 to 5.97). Bids also were independently associated with the probability of being willing to pay, and this association followed a quadratic effect. Below $1500, bid had little impact on patient answers. However, as prices increased, the probability of being willing to pay started to decrease sharply. Conclusion-The potential to eliminate the risk of restenosis, a benign complication, would have substantial value for patients undergoing PCI. (Circ Cardiovasc Qual Outcomes. 2011;4:46-52.)
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [41] Evaluation of willingness to pay per quality-adjusted life year for a cure A contingent valuation method using a scenario-based survey
    Song, Hyun Jin
    Lee, Eui-Kyung
    MEDICINE, 2018, 97 (38)
  • [42] Quantitative contrast stress echocardiography in assessment of restenosis after percutaneous coronary intervention in stable coronary artery disease
    Lonnebakken, Mai Tone
    Staal, Eva M.
    Bleie, Oyvind
    Strand, Elin
    Nygard, Ottar K.
    Gerdts, Eva
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2009, 10 (07): : 858 - 864
  • [43] Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention
    He, Wenbo
    Xu, Changwu
    Wang, Xiaoying
    Lei, Jiyong
    Qiu, Qinfang
    Hu, Yingying
    Luo, Da
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [44] Association of coronary microvascular dysfunction with restenosis of left anterior descending coronary artery disease treated by percutaneous intervention
    De Vita, Antonio
    Milo, Maria
    Sestito, Alfonso
    Lamendola, Priscilla
    Lanza, Gaetano A.
    Crea, Filippo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 219 : 322 - 325
  • [45] Cancer patients' willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network
    Havet, Nathalie
    Morelle, Magali
    Remonnay, Raphael
    Carrere, Marie-Odile
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (03) : 289 - 300
  • [46] Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel
    Ben-Aharon, Omer
    Sergienko, Ruslan
    Iskrov, Georgi
    Greenberg, Dan
    ISRAEL JOURNAL OF HEALTH POLICY RESEARCH, 2024, 13 (01)
  • [47] COST-BENEFIT ANALYSIS INVOLVING ADDICTIVE GOODS: CONTINGENT VALUATION TO ESTIMATE WILLINGNESS-TO-PAY FOR SMOKING CESSATION
    Weimer, David L.
    Vining, Aidan R.
    Thomas, Randall K.
    HEALTH ECONOMICS, 2009, 18 (02) : 181 - 202
  • [48] Vitamin A:: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention?
    Gidlof, Andreas C.
    Ocaya, Pauline
    Krivospitskaya, Olesya
    Sirsjo, Allan
    CLINICAL SCIENCE, 2008, 114 (1-2) : 19 - 25
  • [49] Height and prognosis following percutaneous coronary intervention
    Frobert, Ole
    Arevstrom, Lilith
    Calais, Fredrik
    James, Stefan K.
    Lagerqvist, Bo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 224 : 188 - 190
  • [50] EVALUATION OF NEOPTERIN AS A MARKER FOR RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    EBER, B
    SCHUMACHER, M
    TATZBER, F
    KAUFMANN, P
    LUHA, O
    ESTERBAUER, H
    GASSER, R
    KLEIN, W
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (02) : 361 - 362